SCHEMBL7490735

SCHEMBL7490735

NN1NN(O)c2ccccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2443953 0.87 GAA (0.33)
Water SCHEMBL4329297 0.85 KDM4E (0.35)
SCHEMBL15160002 0.71 MAOA (0.33)
SCHEMBL15432229 0.71 P2RX4 (0.31)
SCHEMBL15158571 0.67 MEN1 (0.31)
SCHEMBL7723598 0.66 MYC (0.34)
SCHEMBL6696758 0.64 CAMK2D (0.32)
SCHEMBL29090289 0.63 CYP2D6 (0.30)
SCHEMBL21082763 0.60 TLR9 (0.43)
SCHEMBL5047321 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560956-B1 NOVEL SYNTHESIS FOR THIAZOLIDINEDIONE COMPOUNDS OCTETA THERAPEUTICS LLC (US) 2016-10-26 EP disclosed
EP-1228067-A1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGYLCEMIC AND HYPOLIPIDEMIC ACTIVITY Takeda Chemical Industries, Ltd. (JP) 2002-08-07 EP disclosed
WO-2001038325-A1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-31 WO disclosed